SUNITINIB 50 mg (Tunib) x 28 Capsules

Uses of SUNITINIB 50 mg

• Treats advanced renal cell carcinoma (RCC)
• Treats gastrointestinal stromal tumours (GIST)
• Treats pancreatic neuroendocrine tumours (pNET)
• Helps slow cancer progression
• Used under the supervision of an oncologist

Benefits of SUNITINIB

• Helps slow the growth of cancer cells
• Reduces the formation of blood vessels that supply tumours
• May help delay disease progression
• Provides a convenient oral treatment option
• Supports long-term cancer management in suitable patients

How Does SUNITINIB 50 mg Work?

Sunitinib 50 mg works by blocking multiple tyrosine kinase receptors, including vascular endothelial growth factor receptors (VEGFR), platelet-derived growth factor receptors (PDGFR), and KIT receptors. By inhibiting these signalling pathways, it slows the growth of cancer cells and reduces the formation of new blood vessels that provide nutrients to tumours.

Side Effects

• Fatigue
• Diarrhoea
• Nausea
• High blood pressure
• Mouth sores
• Hand-foot syndrome
• Loss of appetite
• Skin discolouration

Precautions

• Use only under the supervision of an oncologist.
• Regular monitoring of blood pressure, liver function, thyroid function, heart function, and blood cell counts may be required.
• Inform your doctor if you have heart disease, liver disease, kidney disease, bleeding problems, or thyroid disease.
• Tell your healthcare provider about all medicines and supplements you are taking to help prevent drug interactions.
• Inform your doctor if you are pregnant, planning a pregnancy, or breastfeeding.
• Report chest pain, severe bleeding, breathing difficulties, persistent fever, or signs of infection immediately.
• Do not stop treatment or change the dose without consulting your healthcare provider.